Acalabrutinib100mg capsules (Calquence ®) is: - indicated for the treatment of patients with mantle cell lymphoma (MCL) who have received at least one prior therapy. - indicated for treatment of patients with chronic lymphocytic leukaemia (CLL)/ small lymphocytic lymphoma (SLL).